Role of p.r.n. Antimuscarinic Medication in the Treatment of Antipsychotic-Induced Extrapyramidal Movement Disorders

Psychiatric Bulletin
doi 10.1192/pb.23.6.368
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Royal College of Psychiatrists

Related search

Family History of Primary Movement Disorders as a Predictor for Neuroleptic-Induced Extrapyramidal Symptoms

British Journal of Psychiatry
MedicinePsychiatryMental Health
2004English

Genome-Wide Association Mapping of Loci for Antipsychotic-Induced Extrapyramidal Symptoms in Mice

Mammalian Genome
Genetics
2011English

Lack of Association Between Antipsychotic-Induced Parkinsonism or Its Subsymptoms and Rs4606 SNP of RGS2 Gene in African-Caribbeans and the Possible Role of the Medication: The Curacao Extrapyramidal Syndromes Study X

Human Psychopharmacology
PsychiatryMental HealthNeurologyPharmacology
2009English

Cholinergic Medication for Antipsychotic-Induced Tardive Dyskinesia

BJ Psych Advances
PsychiatryMental Health
2018English

Extrapyramidal Symptoms in Patients Treated With Antipsychotic Drugs

Journal of Bioequivalence & Bioavailability
2017English

Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects

Frontiers in Pharmacology
Pharmacology
2019English

Neurosurgical Treatment of Movement Disorders

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2000English

Drug-Induced Movement Disorders

Expert Opinion on Drug Safety
MedicinePharmacology
2015English

Drug Induced Movement Disorders

Movement Disorders
Neurology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy